000 01592 a2200433 4500
005 20250513204120.0
264 0 _c20000412
008 200004s 0 0 eng d
022 _a1040-8428
024 7 _a10.1016/s1040-8428(99)00042-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeonard, R C
245 0 0 _aIdarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer.
_h[electronic resource]
260 _bCritical reviews in oncology/hematology
_cJan 2000
300 _a61-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Congress; Multicenter Study
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAgranulocytosis
_xchemically induced
650 0 4 _aAntibiotics, Antineoplastic
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDisease Progression
650 0 4 _aFatigue
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIdarubicin
_xadministration & dosage
650 0 4 _aInfections
_xchemically induced
650 0 4 _aMiddle Aged
650 0 4 _aThrombocytopenia
_xchemically induced
700 1 _aCameron, D A
700 1 _aAnderson, A
700 1 _aOstrowski, J
700 1 _aHowell, A
773 0 _tCritical reviews in oncology/hematology
_gvol. 33
_gno. 1
_gp. 61-6
856 4 0 _uhttps://doi.org/10.1016/s1040-8428(99)00042-6
_zAvailable from publisher's website
999 _c10668874
_d10668874